Synthetic Biology: Is Scientific Progress Outrunning Normative Process? Case Of The CBD 30/03/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A research group announced in March that it has designed the first minimal synthetic bacterial cell. Rapid advances in science seem to be leaving the international normative process lagging behind. Current international instruments are seeking to understand how this new technology will impact their regulatory efforts, while civil society raises high concerns.
Despite Supreme Court Ruling, Foreign Sales Don’t Affect US Patent Rights 29/03/2016 by Steven Seidenberg for Intellectual Property Watch Leave a Comment The controversial ruling was perhaps to be expected. The Federal Circuit Court of Appeals doggedly hewed to its existing interpretation of patent law. Unfortunately, the court’s decision in Lexmark International v Impression Products conflicts with recent Supreme Court jurisprudence, according to many experts – thus leaving unresolved some important questions about how much control patentees can maintain over their patented products.
WHO: Developing Countries Need Smart IP Systems For Local Medicines Production 25/03/2016 by Catherine Saez, Intellectual Property Watch 2 Comments The World Health Organization has released a report on the role of intellectual property in local production of medicines in developing countries. According to the report, the way countries design their intellectual property system is key in the development of local innovation and production. However, health outcomes will depend on the accessibility and affordability of good-quality essential medicines.
Biotherapeutic Medicines, A New Frontier, Face Regulatory Issues 24/03/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Biotherapeutic medicines, engineered by living organisms, have opened a promising path to treat major diseases. Near copies of these medicines, called biosimilars, are slowly coming to market, as the originator products become free of intellectual property rights or data protection. However, some regulatory issues are left to be addressed, in particular in developing countries, according to the pharmaceutical industry and the World Health Organization. For patients, information on those products and their affordability are key, said a patient group representative.
Leading US TV Operators In IP Clash With Russian TV Channels 24/03/2016 by Eugene Gerden for Intellectual Property Watch Leave a Comment Leading Russian television channels, among which are First Channel, STS, Ren TV, TNT the Comedy, Nostalgia and some others, have filed a class action lawsuit related to intellectual property rights in a New York court against their US repeaters, including Infomir, Panorama TV, Goodzone TV.
Geographical Indications In The TTIP: Faites Vos Jeux 23/03/2016 by Monika Ermert for Intellectual Property Watch Leave a Comment Ever heard of Törkölypálinka? It is a Hungarian grape marc spirit and one of approximately 200 geographical origins listed by the European Commission negotiators of the Transatlantic Trade and Investment Partnership (TTIP). In their newly published proposals, the EU negotiators laid out their ideas on GI protection in the deal, and point to an earlier EU-US agreement with regard to GI protection of wines and spirits. But they also acknowledge the need for considerable bridging between the two systems. GI protection is expected to be one of the highly controversial issues in the “end game” of TTIP.
South Africa: New Prominent Pro-IP Academic Comes Out Against Government 23/03/2016 by Intellectual Property Watch 2 Comments The new Anton Mostert Chair of Intellectual Property Law at the University of Stellenbosch in South Africa, Professor Sadulla Karjiker, has pointed a finger at the country’s Department of Trade and Industry (DTI) for being “unresponsive” to stakeholders offering their input into proposed IP legislation.
Special Report: India Rocked By Report Of Secret Assurance To US Industry On IP 22/03/2016 by Patralekha Chatterjee for Intellectual Property Watch 2 Comments That the Indian government has been under pressure from the United States to change its patent regime is no secret among those who follow the public discourse on intellectual property rights. Now, a new controversy about India’s alleged private assurance to the US-India Business Council (USIBC) and other lobby groups that it would not invoke compulsory licensing for commercial purposes seeks to add fuel to fiery speculation about a shift in India’s policy on IPR.
African Tech Start-Ups Face Many Challenges 21/03/2016 by Munyaradzi Makoni for Intellectual Property Watch 1 Comment DAKAR, Senegal – Rachel Sibande won accolades when she started Malawi’s first ever technology start-up mHub in 2013.
UN High-Level Panel: Ideas For Change To Global Health And IP System Proliferate 19/03/2016 by William New and Catherine Saez, Intellectual Property Watch 3 Comments Public health advocates, academics, patients, governments and others this week presented further ideas to the United Nations Secretary-General’s High-Level Panel on Access to Medicines on ways to break the longstanding pattern of expensive medical products around the world as a way to pay for research and development.